Paper39725974
Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.
Xu W and 11 others. J Nanobiotechnology, 2024. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer. Papers, record 39725974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39725974
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Camptothecin | Major topic |
| Reactive Oxygen Species | Major topic |
| Immunotherapy | Major topic |
| Phototherapy | Major topic |
| Nanoparticles | Major topic |
| Animals | |
| Female | |
| Mice | |
| Humans | |
| Cell Line, Tumor | |
| Hyaluronic Acid | |
| Antineoplastic Agents | |
| Mice, Inbred BALB C | |
| Indoles | |
| Mice, Nude |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82373295 | National Natural Science Foundation of China | PubMed | ||
| 2024JJ4081 | Natural Science Foundation of Hunan Province | PubMed | ||
| 2023M733962 | China Postdoctoral Science Foundation | PubMed | ||
| GZB20230873 | Postdoctoral Fellowship Program of CPSF, China | PubMed | ||
| QH20230269 | The Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University | PubMed | ||
| 2022XQLH103 | Joint Innovation Program for Postgraduates of Central South University and Enterprises | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38280861 | In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing. | Nat Commun | 2024 | https://conductscience.org/library/papers/38280861 | PubMed |
| 2 | 28891273 | Self-Assembly of an Amphiphilic Janus Camptothecin-Floxuridine Conjugate into Liposome-Like Nanocapsules for More Efficacious Combination Chemotherapy in Cancer. | Adv Mater | 2017 | https://conductscience.org/library/papers/28891273 | PubMed |
| 3 | 28073672 | The long story of camptothecin: From traditional medicine to drugs. | Bioorg Med Chem Lett | 2017 | https://conductscience.org/library/papers/28073672 | PubMed |
| 4 | 35846843 | Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy. | Bioact Mater | 2023 | https://conductscience.org/library/papers/35846843 | PubMed |
| 5 | 34562837 | NIR-triggerable ROS-responsive cluster-bomb-like nanoplatform for enhanced tumor penetration, phototherapy efficiency and antitumor immunity. | Biomaterials | 2021 | https://conductscience.org/library/papers/34562837 | PubMed |
| 6 | 29666625 | Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy. | Front Immunol | 2018 | https://conductscience.org/library/papers/29666625 | PubMed |
| 7 | 25119147 | Development and evaluation of magnetic microemulsion: tool for targeted delivery of camptothecin to BALB/c mice-bearing breast cancer. | J Drug Target | 2014 | https://conductscience.org/library/papers/25119147 | PubMed |
| 8 | 29253923 | IR 780-loaded hyaluronic acid micelles for enhanced tumor-targeted photothermal therapy. | Carbohydr Polym | 2018 | https://conductscience.org/library/papers/29253923 | PubMed |
| 9 | 37323948 | Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37323948 | PubMed |
| 10 | 38444205 | Three-in-One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium-Induced Drug Resistance and Potentiating Anti-Cancer Immune Response. | Adv Mater | 2024 | https://conductscience.org/library/papers/38444205 | PubMed |
| 11 | 37992239 | Laser-Ignited Lipid Peroxidation Nanoamplifiers for Strengthening Tumor Photodynamic Therapy Through Aggravating Ferroptotic Propagation and Sustainable High Immunogenicity. | Small | 2024 | https://conductscience.org/library/papers/37992239 | PubMed |
| 12 | 20568000 | Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imaging. | Pharm Res | 2010 | https://conductscience.org/library/papers/20568000 | PubMed |
| 13 | 28135088 | Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. | J Med Chem | 2017 | https://conductscience.org/library/papers/28135088 | PubMed |
| 14 | 31188559 | High Co-loading Capacity and Stimuli-Responsive Release Based on Cascade Reaction of Self-Destructive Polymer for Improved Chemo-Photodynamic Therapy. | ACS Nano | 2019 | https://conductscience.org/library/papers/31188559 | PubMed |
| 15 | 28165223 | Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. | ACS Nano | 2017 | https://conductscience.org/library/papers/28165223 | PubMed |
| 16 | 10742577 | Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. | J Control Release | 2000 | https://conductscience.org/library/papers/10742577 | PubMed |
| 17 | 27785019 | GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy. | Int J Nanomedicine | 2016 | https://conductscience.org/library/papers/27785019 | PubMed |
| 18 | 34860505 | A Tumor-Targeting Near-Infrared Heptamethine Cyanine Photosensitizer with Twisted Molecular Structure for Enhanced Imaging-Guided Cancer Phototherapy. | J Am Chem Soc | 2021 | https://conductscience.org/library/papers/34860505 | PubMed |
| 19 | 26322900 | Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes. | ACS Appl Mater Interfaces | 2015 | https://conductscience.org/library/papers/26322900 | PubMed |
| 20 | 37914681 | Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity. | Nat Commun | 2023 | https://conductscience.org/library/papers/37914681 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42801248 | Advances in Drug Delivery Systems for Breast Cancer: From Microenvironment Barriers and Smart Carriers to Clinical Translation Strategies. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42801248 | PubMed |
| 42696263 | Ethnobotany-guided exploration of plant-derived photosensitizer candidates for photodynamic therapy. | Photochem Photobiol Sci | 2026 | https://conductscience.org/library/papers/42696263 | PubMed |
| 42695488 | Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS-Responsive Therapeutics. | Cell Biochem Funct | 2026 | https://conductscience.org/library/papers/42695488 | PubMed |
| 42514963 | TPGS Analog-Mediated Intracellular ROS-Amplifying Strategy Potentiates the In Vitro Anticancer Activity of a Dual-Thioketal-Linked Polymeric Drug Conjugate in A549 Lung Cancer Cells. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514963 | PubMed |
| 42357328 | Advances in Camptothecin-Class Compounds Nanomedicines: A Comprehensive Review of Antitumor Strategies. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357328 | PubMed |
| 42201430 | A Bibliometric Review and Knowledge Mapping of Microplastics and Nanoplastics in Cardiovascular Research. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42201430 | PubMed |
| 42075806 | Bioactive Natural Compounds in Triple-Negative Breast Cancer: Molecular Targets and Therapeutic Perspectives. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075806 | PubMed |
| 41731105 | Role of laser therapy in enhancing chemotherapy efficiency in breast cancer: low level laser therapy, photochemotherapy, and photodynamic therapy as promising treatments. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/41731105 | PubMed |
| 41660115 | Immediate tumor killing and long-term anti-tumor immunoreaction induced by Bufalin-loaded phototherapeutic Janus membrane in CRC postoperative therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41660115 | PubMed |
| 41613221 | Nanobiotechnology-driven advances in sonodynamic therapy: unlocking the potential of sonosensitizers in clinical translation. | RSC Adv | 2026 | https://conductscience.org/library/papers/41613221 | PubMed |
| 41528374 | Camptothecin Nanoformulations: Recent Advances in Preparation, Bioactivities, and Clinical Perspectives. | Ann Biomed Eng | 2026 | https://conductscience.org/library/papers/41528374 | PubMed |
| 41168838 | Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41168838 | PubMed |
| 41041069 | Hot-spot empowered gold nanoparticles for theranostics in breast cancer. | Theranostics | 2025 | https://conductscience.org/library/papers/41041069 | PubMed |
| 40863842 | Advancements in Tumor-Targeted Nanoparticles: Design Strategies and Multifunctional Therapeutic Approaches. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/40863842 | PubMed |
| 40733095 | ROS-Responsive Nanoplatforms for Targeted Tumor Immunomodulation: A Paradigm Shift in Precision Cancer Immunotherapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733095 | PubMed |
| 40725126 | Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725126 | PubMed |
| 40685358 | Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatment. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40685358 | PubMed |
| 40040956 | Biomimetic Atorvastatin Self-Assembled Nanomedicine Inhibits the Cyclooxygenase-2/Prostaglandin E2 Pathway Enhanced Photothermal and Antitumor Immunity. | Biomater Res | 2025 | https://conductscience.org/library/papers/40040956 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39725974
GET https://conductscience.org/api/papers/v1/39725974/references?page=2